Abstract:BackgroundCardiac arrhythmia is a common disease associated with high mortality and morbidity. Circulating leukocyte counts, which serve as a biomarker for assessing systemic immune status, have been linked to arrhythmias in observational studies. However, observational studies are plagued by confounding factors and reverse causality, whether alterations in circulating leukocyte components are causally associated with arrhythmias remains uncertain. The present study explored this question based on genetic evidence.Methods and findingsWe performed Mendelian randomization (MR) analysis to evaluate whether alterations in leukocyte counts affect aggregated risk of all types of arrhythmia or risk of five specific types of arrhythmia. Single-nucleotide polymorphisms serving as proxies for leukocyte differential counts were retrieved from the Blood Cell Consortium, and statistical data on arrhythmias were obtained from the UK Biobank), FinnGenand a meta-analysis of genome-wide association studies for atrial fibrillation. We applied inverse variance-weighted method as the primary analysis, complemented by a series of sensitivity analyses. Bidirectional analyses were conducted to assess reverse causality. Finally, multivariable MR was performed to study the joint effects of multiple risk factors. We found that genetically predicted differential leukocyte counts were not significantly associated with aggregated occurrence of all types of arrhythmia. In contrast, each 1-standard deviation increase in lymphocyte count was associated with 46% higher risk of atrioventricular block (OR 1.46, 95% CI 1.11–1.93, p=0.0065). A similar effect size was observed across all MR sensitivity analyses, with no evidence of horizontal pleiotropy. Reverse MR analysis suggested that atrioventricular block was unlikely to cause changes in lymphocyte count. Primary MR analysis based on the inverse-variance weighted method suggested that changes in neutrophil count alter risk of right bundle branch block, and changes in basophil count alter risk of atrial fibrillation. However, these causal relationships were not robust in sensitivity analyses. We found no compelling evidence that neutrophil or lymphocyte counts cause atrial fibrillation.ConclusionOur data support higher lymphocyte count as a causal risk factor for atrioventricular block. These results highlight the importance of immune cells in the pathogenesis of specific cardiac conduction disorders.

The white blood cell count and risk for coronary heart disease

Prognostic Importance of the White Blood Cell Count for Coronary, Cancer, and All-Cause Mortality

Predictive value of the relative lymphocyte count in coronary heart disease

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?

White blood cell counts can predict 4-year cardiovascular disease risk in patients with stable coronary heart disease: a prospective cohort study

The Peripheral Blood Mononuclear Cell Count is Associated with Bone Health in Elderly Men

Association Between Circulating Leukocytes and Arrhythmias: Mendelian Randomization Analysis in Immuno-Cardiac Electrophysiology

White blood cell count as a predictor of mortality: Results over 18 years from the normative aging study

High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk

Higher monocyte count with normal white blood cell count is positively associated with 10-year cardiovascular disease risk determined by Framingham risk score among community-dwelling Korean individuals

White blood cell count predicts the odds of kidney function decline in a Chinese community-based population

White blood cell count associates with peripheral arterial disease in a Chinese community-based population

WBC Count Predicts the Risk of New-Onset Peripheral Arterial Disease in a Chinese Community-Based Population.

Carotid artery plaque thickness and elevated white blood cell count

Prognostic impact of white blood cell counts on clinical outcomes in patients with chronic renal insufficiency undergoing percutaneous coronary intervention

Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease

Relationship Between Leukocyte Count and Angiographical Characteristics of Coronary Atherosclerosis

Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study

Predictive Values of White Blood Cell Count in Peripheral Blood at Admission on In-Hospital Complications and 90-Day Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage: Insights from the LongTEAM Registry

Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome

Elevated white blood cell count and long-term clinical outcomes of patients with vasospastic angina